CA
NZ
UK
AU
IND
US
• Mixed Analyst Landscape: Goldman Sachs nudged its price target to 310 Danish kroner while Morningstar downgraded the stock to Hold.
• FDA Accepts Supplemental Applications: Applications for Amondys 45 and Vyondys 53 were accepted, setting a PDUFA target date of February 28, 2027.
• 11% Weekly Gain Extended: Rivian is extending strong recent momentum as investors position ahead of the early July delivery report.
• eBay Board Rejects Takeover Offer: CEO Ryan Cohen has pledged to press forward with the bid despite the rejection.
• First Major US Retail Rollout: The mycelium-based Beyond Steak Filet launched at Wegmans and H-E-B stores, marking a significant retail milestone.
• X-Mind World Model Unveiled: The next-generation autonomous driving framework was trained on hundreds of millions of real-world driving frames.
• Underperforming Broader Tech Rally: NOW is declining even as the XLK technology ETF and S&P 500 trade higher amid US-Iran ceasefire relief.
• $1.9 Billion VAC Acquisition: The landmark acquisition of German magnet producer VAC was announced June 23, expanding into rare earths production.
• Unanimous Strong Buy Consensus: Wall Street maintains an average price target of $18.25, nearly double the current stock level.
• Strong Safety Record Reported: 1.69 million work hours with zero lost-time incidents and zero regulatory non-compliance at Thacker Pass.
Please wait processing your request...